Safety of fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: A prospective randomized clinical trial

International Journal of Urology

Volumn 23, Issue 11, 2016, Pages 923-928

  Hata, Kenichi ^a   Kimura, Takahiro ^a   Tsuzuki, Shunsuke ^a   Ishii, Gen ^a   Kido, Masahito ^a   Yamamoto, Toshihiro ^a   Sasaki, Hiroshi ^a   Miki, Jun ^a   Yamada, Hiroki ^a   Furuta, Akira ^a   Miki, Kenta ^a   Egawa, Shin ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

fondaparinux; thromboprophylaxis; urological malignancy; urological surgery; venous thromboembolism

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; D DIMER; ENOXAPARIN; FIBRIN MONOMER; FONDAPARINUX; HEMOGLOBIN; HEPARIN; ANTICOAGULANT AGENT; POLYSACCHARIDE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTICOAGULANT THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; CANCER PATIENT; CANCER SURGERY; CLINICAL EVALUATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOMA; HEMATURIA; HEPARINIZATION; HUMAN; INFERIOR CAVA VEIN; LEG EDEMA; LOW DRUG DOSE; LUNG EMBOLISM; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPHADENECTOMY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; THROMBOCYTE; THROMBOSIS PREVENTION; URINARY TRACT CANCER; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; URINARY TRACT TUMOR;

ANTICOAGULANTS; HEPARIN; HUMANS; POLYSACCHARIDES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; UROLOGIC NEOPLASMS; VENOUS THROMBOEMBOLISM;

EID: 84982221801     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.13189     Document Type: Article

References (27)

1. Moser KM, Fedullo PF, LitteJohn JK, Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 1994; 271: 223–5.
2. Kearon C. Diagnosis of pulmonary embolism. CMAJ 2003; 168: 183–94.
3. Sterious S, Simhan J, Uzzo RG et al. Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members. J. Urol. 2013; 190: 992–8.
4. Agnelli G, Bolis G, Capussotti L et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann. Surg. 2006; 243: 89–95.
5. Clement C, Rossi P, Aissi K et al. Incidence, risk profile and morphological pattern of lower extremity venous thromboembolism after urological cancer surgery. J. Urol. 2011; 186: 2293–7.
6. Secin FP, Jiborn T, Bjartell AS et al. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy. Eur. Urol. 2008; 53: 134–45.
7. Roghmann F, Trinh QD, Braun K et al. Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy. Int. J. Urol. 2014; 21: 143–9.
8. Dyer J, Wyke S, Lynch C. Hospital Episode Statistics data analysis of postoperative venous thromboembolus in patients undergoing urological surgery: a review of 126,891 cases. Ann. R. Coll. Surg. Engl. 2013; 95: 65–9.
9. Nomura T, Takahashi M, Iwasaki K et al. Efficacy and safety of enoxaparin for preventing venous thromboembolic events following urologic laparoscopic surgery. ISRN Urol. 2013; 2013: 415918.
10. Scarpa RM, Carrieri G, Gussoni G et al. Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study. Eur. Urol. 2007; 51: 130–5.
11. Covey TH, Sherman L, Baue AE. Low-dose heparin in postoperative patients: a prospective, coded study. Arch. Surg. 1975; 110: 1021–6.
12. Coe NP, Collins RE, Klein LA et al. Prevention of deep vein thrombosis in urological patients: a controlled, randomized trial of low-dose heparin and external pneumatic compression boots. Surgery 1978; 83: 230–4.
13. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group. Br. J. Surg. 1997; 84: 1099–103.
14. Kearon C, Akl EA, Comerota AJ et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e419S–94S.
15. Forrest JB, Clemens JQ, Finamore P et al. AUA best practice statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery. J. Urol. 2009; 181: 1170–7.
16. Agnelli G, Bergqvist D, Cohen AT et al. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br. J. Surg. 2005; 92: 1212–20.
17. Petitou M, Lormeau JC, Choay J. Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs. Nature 1991; 350(6319 Suppl): 30–3.
18. Caliezi C, Funfsinn N, Mauron T et al. Performance of a new fibrin monomer assay to exclude deep vein thrombosis in symptomatic outpatients. Thromb. Haemost. 1999; 81: 50–3.
19. Yoshioka K, Kitajima I, Kabata T et al. Venous thromboembolism after spine surgery: changes of the fibrin monomer complex and D-dimer level during the perioperative period. J. Neurosurg. Spine 2010; 13: 594–9.
20. Sudo A, Wada H, Nobori T et al. Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery. Int. J. Hematol. 2009; 89: 572–6.
21. Gould MK, Garcia DA, Wren SM et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e227S–77S.
22. Sakon M, Kobayashi T, Shimazui T. Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study. Thromb. Res. 2010; 125: e65–70.
23. Leonardi MJ, McGory ML, Ko CY. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch. Surg. 2006; 141: 790–7.
24. Turpie AG, Bauer KA, Eriksson BI et al. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch. Intern. Med. 2002; 162: 1833–40.
25. Jessie BC, Marshall FF. Pharmacological prophylaxis of venous thromboembolism in contemporary radical retropubic prostatectomy: does concomitant pelvic lymphadenectomy matter? Int. J. Urol. 2008; 15: 951–6.
26. Prell J, Rachinger J, Smaczny R et al. D-dimer plasma level: a reliable marker for venous thromboembolism after elective craniotomy. J. Neurosurg. 2013; 119: 1340–6.
27. Sasaki S, Miyakoshi N, Matsuura H et al. Prospective randomized controlled trial on the effect of fondaparinux sodium for prevention of venous thromboembolism after hip fracture surgery. J. Orthop. Sci. 2009; 14: 491–6.